Clinical trial • Phase III • Gastroenterology
Clinical trial in Cholangitis
Phase III trial for Cholangitis. 56 participants.
Overview
- Trial Therapeutic Area
- Gastroenterology
- Trial Disease
- Cholangitis
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 09-08-2024
- First CTIS Authorization Date
- 08-09-2024
Trial design
Phase III trial across 1 site in Austria.
- Target Sample Size
- 56
- Trial Duration For Participant
- 601
Eligibility
Recruits 56 Vulnerable population not selected; no special consent or assent handling described..
- Vulnerable Population
- Vulnerable population not selected; no special consent or assent handling described.
Recruitment
- Planned Sample Size
- 56
- Recruitment Window Months
- 19
Geography
- Total Number Of Sites
- 1
- Total Number Of Participants
- 56
Austria
- Earliest CTIS Part Ii Submission Date
- 20-08-2024
- Latest Decision Or Authorization Date
- 08-09-2024
- Processing Time Days
- 19
- Number Of Sites
- 1
- Number Of Participants
- 56
Sites
- Site Name
- Medical University Of Vienna
- Department Name
- Department of Clinical Pharmacology
- Principal Investigator Name
- Markus Zeitlinger
- Principal Investigator Email
- markus.zeitlinger@meduniwien.ac.at
- Contact Person Name
- Markus Zeitlinger
- Contact Person Email
- markus.zeitlinger@meduniwien.ac.at
- Number Of Participants
- 56
Sponsor
Primary sponsor
- Full Name
- Medical University Of Vienna
- Organisation Type
- Educational Institution
- Country Of Registered Address
- Austria
Related trials
Other published trials that may interest you.